Dr. Ashfaq S. Balla, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 348
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
MA license 242372
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Umass Memorial Medical Center/university Campus Worcester, MA
- Umass Memorial Health - Harrington Hospital Southbridge, MA
- Milford Regional Medical Center Milford, MA
- Marlborough Hospital Marlborough, MA
Medical groups
- Umass Memorial Medical Group Inc (2,516 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 348
- Services billed
- 975
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 191 | 94 |
| Established patient office or other outpatient visit, 30-39 minutes | 153 | 90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 110 | 62 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 81 | 78 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 70 | 18 |
| Hemodialysis procedure with physician evaluation | 63 | 38 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 57 | 15 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Losartan Potassium Other prescribers in Worcester, MA | 111 |
| Amlodipine Besylate Other prescribers in Worcester, MA | 77 |
| Furosemide Other prescribers in Worcester, MA | 56 |
| Sevelamer Carbonate Other prescribers in Worcester, MA | 44 |
| Carvedilol Other prescribers in Worcester, MA | 41 |
| Lisinopril Other prescribers in Worcester, MA | 39 |
| Spironolactone Other prescribers in Worcester, MA | 35 |
| Veltassa (patiromer calcium sorbitex) | 32 |
| Hydralazine Hcl Other prescribers in Worcester, MA | 28 |
| Allopurinol Other prescribers in Worcester, MA | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 4 payments worth $6.64 in total to this clinician.
| Travere Therapeutics, Inc. | $6.64 |
|---|
| Education | $6.64 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. May 6, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Jun 25, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Jul 21, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Aug 26, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.